Antimetabolites: all 7,305 studies that test it

Page 28 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.

• Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00301808Phase 2Results posted
• D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic PainTerminatedNCT00301080Phase 3Results posted
• Oral Clofarabine Study in Patients With Myelodysplastic SyndromeCompletedNCT00299156Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid ArthritisCompletedNCT00299130Phase 3Results posted
• Trial of Adjuvant Chemotherapy for Gastric CancerCompletedNCT00296335Phase 3Results posted
• Trial of Adjuvant Chemotherapy for Gastric CancerCompletedNCT00296322Phase 3Results posted
• Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant MesotheliomaCompletedNCT00295503Phase 2Results posted
• Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck CancerCompletedNCT00293579Phase 2Results posted
• Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal CancerCompletedNCT00291486Phase 1Results posted
• Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)TerminatedNCT00290771Phase 2Results posted
• A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaTerminatedNCT00290706Phase 1/2Results posted
• Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic CancerCompletedNCT00290693Phase 2Results posted
• Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00290615Phase 2Results posted
• Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular LymphomaCompletedNCT00290511Phase 2Results posted
• Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or YoungerCompletedNCT00290498Phase 2Results posted
• Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell LymphomaCompletedNCT00290433Phase 2Results posted
• Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLCCompletedNCT00283244Phase 2Results posted
• Rheumatoid Arthritis:Tolerance Induction by Mixed ChimerismTerminatedNCT00282412Phase 1Results posted
• Adjuvant Chemotherapy for High Risk Uterine LeiomyosarcomaCompletedNCT00282087Phase 2Results posted
• Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerTerminatedNCT00281879Phase 2Results posted
• Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung CancerTerminatedNCT00281827Phase 2Results posted
• Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung CancerTerminatedNCT00280748Phase 2Results posted
• Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00280241Phase 2Results posted
• Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized TrialCompletedNCT00278863Phase 2Results posted
• Hematopoietic Stem Cell Support in VasculitisTerminatedNCT00278512Phase 1Results posted
• Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon CancerTerminatedNCT00276861Phase 2Results posted
• Individualized Drug Treatment for Treating Patients With Pancreatic CancerTerminatedNCT00276744Phase 2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00276549Phase 2Results posted
• Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00274846Phase 2Results posted
• Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00274768Phase 2Results posted
• Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal CancerTerminatedNCT00268463Phase 3Results posted
• Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By SurgeryTerminatedNCT00268450Phase 2Results posted
• Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By SurgeryTerminatedNCT00268437Phase 2Results posted
• Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid LeukemiaTerminatedNCT00268242Phase 2Results posted
• Chemotherapy and HAART to Treat AIDS-related Primary Brain LymphomaCompletedNCT00267865Phase 2Results posted
• Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedNCT00267696Phase 2Results posted
• Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck MalignanciesCompletedNCT00266279Phase 2Results posted
• S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00265785Phase 2Results posted
• An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00264550Phase 3Results posted
• A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naiveCompletedNCT00264537Phase 3Results posted
• Chemoradiation in Locally Advanced Pancreatic CancerTerminatedNCT00262951Phase 2Results posted
• Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaTerminatedNCT00262925Phase 2Results posted
• Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00262860Phase 2Results posted
• A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic SyndromesCompletedNCT00260065Phase 2Results posted
• Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung CancerTerminatedNCT00259285Phase 2Results posted
• Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or ChemoCompletedNCT00258310Phase 2Results posted
• Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck CancerTerminatedNCT00256295Phase 2Results posted
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerTerminatedNCT00255684Not applicableResults posted
• FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 YearsCompletedNCT00254410Phase 2Results posted
• Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeCompletedNCT00253513Phase 1/2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck CancerCompletedNCT00248560Phase 2Results posted
• Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00248495Phase 2Results posted
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00245037Phase 1/2Results posted
• Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast CancerCompletedNCT00244933Phase 2Results posted
• A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving MethotrexateCompletedNCT00243412Phase 2Results posted
• Uric Acid and Hypertension in African AmericansCompletedNCT00241839Phase 3Results posted
• Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell CancerCompletedNCT00234494Phase 2Results posted
• Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00234052Phase 2Results posted
• S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-GuerinCompletedNCT00234039Phase 2Results posted
• Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00230282Phase 2Results posted
• Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis SyndromeCompletedNCT00230178Phase 3Results posted
• Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal CancerCompletedNCT00227721Phase 2Results posted
• Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00227539Phase 2Results posted
• Phase 2 Trial of Bevacizumab in Combination With PemetrexedCompletedNCT00227019Phase 2Results posted
• A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal CancerTerminatedNCT00226941Phase 1/2Results posted
• Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLCCompletedNCT00226590Phase 2Results posted
• Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.CompletedNCT00226577Phase 2Results posted
• Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic CancerCompletedNCT00225784Phase 2Results posted
• Study of Pemetrexed and Bevacizumab in Patients With Head and Neck CancerCompletedNCT00222729Phase 2Results posted
• Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerCompletedNCT00217737Phase 3Results posted
• Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung CancerCompletedNCT00216203Phase 1/2Results posted
• Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate CancerCompletedNCT00216099Phase 2Results posted
• Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal CancerTerminatedNCT00216086Phase 2Results posted
• The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung CancerCompletedNCT00215930Phase 2Results posted
• A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)CompletedNCT00213135Phase 3Results posted
• Randomized Phase II Trial Induction Therapy for Early Stage Breast CancerCompletedNCT00209092Phase 2Results posted
• Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and RituximabTerminatedNCT00208975Phase 2Results posted
• Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)CompletedNCT00206726Phase 2Results posted
• Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung CancerTerminatedNCT00203931Phase 2Results posted
• Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00203411Phase 2Results posted
• A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer PatientsCompletedNCT00201825Phase 2Results posted
• Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown PrimaryTerminatedNCT00201734Phase 1/2Results posted
• Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic CarcinomaCompletedNCT00198133Phase 2Results posted
• Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With AutismCompletedNCT00198107Phase 3Results posted
• Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid ArthritisCompletedNCT00195663Phase 3Results posted
• Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerTerminatedNCT00194792Phase 2Results posted
• Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryCompletedNCT00194779Phase 2Results posted
• Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary SiteCompletedNCT00193609Phase 2Results posted
• Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary SiteCompletedNCT00193596Phase 3Results posted
• Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung CancerCompletedNCT00193453Phase 2Results posted
• Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung CancerCompletedNCT00193427Phase 2Results posted
• Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00193414Phase 2Results posted
• Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal CancerCompletedNCT00193219Phase 2Results posted
• Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast CancerCompletedNCT00193206Phase 2Results posted
• Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast CancerCompletedNCT00193063Phase 2Results posted
• Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast CancerCompletedNCT00193050Phase 2Results posted
• A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal CancerCompletedNCT00192075Phase 2Results posted
• Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung CancerCompletedNCT00192036Phase 2Results posted
• A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal CancerCompletedNCT00191984Phase 2Results posted
• Combination Chemotherapy for Metastatic Breast CancerCompletedNCT00191815Phase 2Results posted

← Antimetabolites overview